OpGen opens clinical services laboratory, launches genetic tests offering for HAIs

Genetic analysis company OpGen (Gaithersburg, MD) has launched a clinical services laboratory that will focus on developing genetic tests and analysis services for the surveillance and identification of healthcare-associated infections (HAIs) and human pathogens. The new lab has received Clinical Laboratory Improvement Amendments (CLIA) certification.

Related: First-ever stoppage of MRSA outbreak by gene sequencing technology

Related: Optical-driven microbial sequence database collaboration in the works

Related: DNA sequencing technologies: The next generation and beyond

The company's clinical services laboratory utilizes next-generation DNA and genetic analysis technologies that include multiplex real-time polymerase chain reaction (PCR), whole genome mapping, and next-generation sequencing for screening, surveillance, diagnosis, gene content, and epidemiologic analysis of infectious diseases. It offers Whole Genome Mapping genetic analysis of HAIs, as well as sequence analysis of C. difficile on a worldwide basis. It will also offer real-time PCR screening and surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and complete C. difficile hyper-virulence diagnostic testing services in the mid-Atlantic region. And they are actively developing tests for a broad array of gram-negative and gram-positive multi-drug-resistant organisms.

"With the significant mortality and costs associated with HAIs along with growing prevalence and concerns surrounding multi-drug resistant organisms, clinicians, hospitals, and public health agencies need to be able to rapidly identify healthcare associated infections to effectively treat patients while minimizing the risk of outbreaks," says Douglas White, chief executive officer of OpGen. "OpGen is building on the success of our Whole Genome Mapping applications in the public health and life sciences sectors to expand our capabilities to help hospitals and healthcare facilities combat HAIs and complex human pathogens."

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

'Lab on a stick' test optically and rapidly detects antibiotic resistance

A point-of-care test, based on the dipstick method, can rapidly detect bacterial resistance to antibiotics in urine.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Microscope detects one million-plus biomarkers for sepsis in 30 minutes

A microscope has the potential to simultaneously detect more than one million biomarkers for sepsis at the point of care.

Flow cytometry analyzes cell population to predict cancer immunotherapy response

Flow cytometry helped find that the amount of white blood cells in melanoma tumors can predict response to a cancer therapy.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS